To the full analysis
Buyback calculator for AngioDynamics
AngioDynamics stock: key metrics
ANGOAngioDynamics had an operating margin of −12.5% and a return on invested capital (ROIC) of −23.8% in fiscal 2026.
Margins show how much of revenue is left over, returns on capital how hard the invested money works.
Daily figure as of 13 Nov 2026
Margins
- Gross margin
- Operating margin
- Net margin
Figures as a table
| Year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| 2007 | 59.0% | −10.0% | −8.1% |
| 2008 | 61.6% | 9.8% | 6.5% |
| 2009 | 61.6% | 8.3% | 5.1% |
| 2010 | 58.8% | 9.7% | 5.7% |
| 2011 | 58.2% | 5.5% | 3.8% |
| 2012 | 56.5% | −1.8% | −2.3% |
| 2013 | 49.3% | 1.8% | −0.4% |
| 2014 | 50.8% | 3.0% | 0.7% |
| 2015 | 49.2% | −1.0% | −0.9% |
| 2016 | 49.3% | 0.3% | −12.3% |
| 2017 | 41.2% | −3.2% | −2.0% |
| 2018 | 41.8% | −4.1% | no data |
| 2019 | 43.4% | −2.6% | no data |
| 2020 | 56.9% | −63.3% | −63.1% |
| 2021 | 53.9% | −12.1% | −10.8% |
| 2022 | 52.4% | −9.0% | −8.4% |
| 2023 | 51.4% | −15.1% | −15.5% |
| 2024 | 50.9% | −63.3% | −60.7% |
| 2025 | 53.9% | −13.7% | −11.6% |
| 2026 | 54.6% | −12.5% | −11.5% |
Returns on capital
- ROE
- ROIC
- ROA
Figures as a table
| Year | ROE | ROIC | ROA |
|---|---|---|---|
| 2007 | −2.7% | −3.1% | −2.4% |
| 2008 | 3.1% | 3.5% | 2.7% |
| 2009 | 2.7% | 3.5% | 2.4% |
| 2010 | 3.1% | 4.3% | 2.9% |
| 2011 | 2.0% | 3.1% | 1.9% |
| 2012 | −1.0% | −0.7% | −0.7% |
| 2013 | −0.2% | 0.8% | −0.2% |
| 2014 | 0.4% | 0.8% | 0.3% |
| 2015 | −0.6% | −0.4% | −0.4% |
| 2016 | −8.6% | 0.1% | −6.0% |
| 2017 | −1.4% | −1.5% | −1.0% |
| 2018 | no data | −2.0% | no data |
| 2019 | no data | −1.4% | no data |
| 2020 | −36.6% | −27.3% | −28.0% |
| 2021 | −7.2% | −6.5% | −5.6% |
| 2022 | −6.3% | −5.4% | −4.8% |
| 2023 | −13.9% | −9.8% | −9.8% |
| 2024 | −89.7% | −57.1% | −58.0% |
| 2025 | −18.6% | −23.3% | −12.1% |
| 2026 | −21.5% | −23.8% | −13.8% |
Data status and sources
- Score
- Daily value of 13 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2026, period end 31 May 2026
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Weak, published since 7 Nov 2026 (in the score history since 31 Oct 2018)
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.